Literature DB >> 27234059

Neuronal endocytosis of anti-ganglioside antibodies: implications for Guillain-Barré syndrome.

Pieter A van Doorn1, Bart C Jacobs2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27234059     DOI： 10.1093/brain/aww078

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  5 in total

Review 1.  Gangliosides play important roles in the nervous system by regulating ion concentrations.

Authors:  Yijia Xu; Jianfang Sun; Liying Yang; Shangfeng Zhao; Xin Liu; Yang Su; Jinghai Zhang; Mingyi Zhao
Journal:  Neurochem Res       Date:  2022-04-15       Impact factor: 3.996

2.  Zika Virus Infection and Guillain-Barré Syndrome in Three Patients from Suriname.

Authors:  Thomas Langerak; Harvey Yang; Mark Baptista; Laura Doornekamp; Tessa Kerkman; John Codrington; Jimmy Roosblad; Stephen G S Vreden; Erwin De Bruin; Ramona Mögling; Bart C Jacobs; Suzan D Pas; Corine H GeurtsvanKessel; Chantal B E M Reusken; Marion P Koopmans; Eric C M Van Gorp; Henk Alberga
Journal:  Front Neurol       Date:  2016-12-22       Impact factor: 4.003

3.  Serum Metabolic Alterations upon Zika Infection.

Authors:  Carlos Fernando O R Melo; Jeany Delafiori; Diogo N de Oliveira; Tatiane M Guerreiro; Cibele Z Esteves; Estela de O Lima; Victoria Pando-Robles; Rodrigo R Catharino
Journal:  Front Microbiol       Date:  2017-10-10       Impact factor: 5.640

4.  Association of anti-gangliosides antibodies and anti-CMV antibodies in Guillain-Barré syndrome.

Authors:  Lijuan Wang; Chunqing Shao; Chunjiao Yang; Xixiong Kang; Guojun Zhang
Journal:  Brain Behav       Date:  2017-04-07       Impact factor: 2.708

Review 5.  Severe Guillain-Barré syndrome after surgery for multiple fractures: a rare case report with a 5-year follow-up and a brief review of the literature.

Authors:  Jian Chen; Jian-Xiong Ma; Cai-Hong Zuo; Qing Zhang; Heng-Ting Chen; Xin-Long Ma
Journal:  BMC Musculoskelet Disord       Date:  2021-01-04       Impact factor: 2.362
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.